Causes for developing bacteremia in mechanically ventilated patients

Recruiting

Conditions: Intraoperative and postprocedural complications and disorders of respiratory system, not elsewhere classified,

Brief Summary: My study is anobservational study, on patients who develop Ventilaor associated pneumonia (VAP) that I will be following up.It involves collecting appropriate data from the patients that develop VAP andsee which patients develop bacteraemia and the probable risk factors for it.

Therefore patients who are admitted in any of the Medical ICUs in the hospital,requiring ventilator assistance in any form, who develop VAP according to the inclusion criteria will be includedin my study. Data about the patients will be collected after taking informedconsent. Information as per my proforma will be collected from these patientssuch as ventilator settings, radiological, microbiological and biochemical willbe collected. These patients will be followed up.

The data collected from these patients will then be compared. Patientswith VAP who develop bacteremia will become cases and those who do not willbecome controls. The data will then be compared, matched and analyzedaccordingly. No active intervention will be done during this study.

Recruitment & Eligibility

Inclusion Criteria

patients who develop ventilator associated pneumonia as defined as, when in a mechanically ventilated patient has: 1.
new persistent pulmonary infiltrates not otherwise explained 2.
purulent respiratory secretions 3.
systemic signs of inflammation.

Exclusion Criteria

inclusion criteria not met -patients in surgical ICUs.

Primary Outcome Measures

Name	Time	Method
To identify the bacteria and the risk factors causing ventilator associated pneumonia (VAP). To reveal the faults in the CDC defined surveillance for VAP as compared to the clinical definition of VAP.	patient will be assessed at the time of admission and at the time of discharge or death

Secondary Outcome Measures

Name	Time	Method
To reveal the faults in the CDC defined surveillance for VAP as compared to the clinical definition of VAP.	2 years

Locations (1): Kasturba Hospital
🇮🇳
Udupi, KARNATAKA, India
Kasturba Hospital
🇮🇳Udupi, KARNATAKA, India
Dr Anisha Umashankar
Principal investigator
9986821460
anishau103@gmail.com